Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Protein activity in female muscles said more efficient… It’s long been known that obese men are more likely to develop type 2 diabetes than obese women, but researchers at McMaster University have discovered it may be related to a difference between the sexes in the activity of a protein in …
Read More »Gastric Electrical Stimulation an Alternative to Insulin Injections?
Device implantation could be the future in T2DM and weight loss… Weight gain is often a side effect of several different oral antidiabetic drugs (OADs), such as sulfonylureas and thiazolidinedion, along with insulin. Lifestyle modification and weight loss is always recommended in T2DM, but we all know it takes great …
Read More »Insulin Resistance – A Survival Mechanism Gone Awry, Part 2
With this week’s Homerun Slides, we look at the current realities of modern life which seem to be encouraging the development of insulin resistance and how Modern Man is "locked" into a "Seasonal Insulin Resistance Syndrome Physiology"…. To download the complete set of slides in PowerPoint (.ppt) format, just use this …
Read More »Insulin Resistance – A Survival Mechanism Gone Awry, Part 1
With this week’s Homerun Slides, we start a short new series on Insulin Resistance put together by Dr. Stanley Schwartz. We begin with a quick overview of the traditional view of the natural history of diabetes as compared to Dr. Schwartz’s newer beta-cell centric model…. To download the complete set …
Read More »New Insulin Formulations – Umpierrez, Part 3
This week’s Homerun Slides finishes up with a conversation on the newer formulations of long acting insulin and how they compare to insulin glargine U100…. To download the complete set in PowerPoint (.ppt) format just use this link: New Insulin Formulations – Umpierrez, Part 3 Other Homerun Slides sets in this …
Read More »New Insulin Formulations – Umpierrez, Part 2
In this week’s Homerun Slides, we review the properties of insulin glargine including U-300 glargine vs U-100 glargine. With the advent of Toujeo on the market, you may want to review these slides….
Read More »Is Toujeo the new Lantus?
Sanofi hoping to convert patients to Toujeo as Lantus is due to lose U.S. patent protection.
Read More »New Insulin Formulations – Umpierrez, Part 1
In this week’s Homerun Slides, we begin a new series from Dr. Guillermo Umpierrez, Professor, Emory University School of Medicine, which will update you on the latest insulin developments, and also delve into exactly how these insulins differ in their effects…. To download the complete set in PowerPoint (.ppt) format …
Read More »Even Experienced Patients Need Reviews of Insulin Injection Technique
A patient came to us on reasonably high doses of basal bolus insulin, using Levemir and NovoLog flex pens. He stated that he had been using insulin for a few months and was referred for more management assistance from his provider. He was seen by a CDE to review his …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #5: Type 1 Diabetes: Insulin Treatment: Part 2 of 2
David Levy, MD, FRCP Insulin Pump Treatment (CSII) First used at the end of the 1970s, insulin pump therapy is standard treatment for type 1 diabetes, although use varies between countries (e.g. about 1–2% in the UK, probably more now; about 25% in USA, up to 40% in Norway). Only rapid-acting …
Read More »